AL Coleman, F Lerner, P Bernstein, SM … - Ophthalmology, 2003 - Elsevier Presented in part at the annual meeting of the American Academy of
Ophthalmology, New Orleans, Louisiana, November 2001; and at the International
Congress of Ophthalmology, Sydney, Australia, April 2002. Cited by 33 - Related articles - All 4 versions
K Hedman, PG Watson, A Alm - Survey of ophthalmology, 2002 - Elsevier Our objective was to study the intraocular pressure (IOP) in open-angle glaucoma
or ocular hypertensive patients during long-term treatment with latanoprost. A
total of 532 patients treated with 0.005% latanoprost were enrolled, ... Cited by 16 - Related articles - All 14 versions
- ►nih.gov TYY Lai, VWY Wong, GM Leung - British Journal of Ophthalmology, 2003 - bjo.bmj.com Results: A total of 274 consecutive consultation episodes were examined. 22
cases were excluded since no diagnosis or intervention was made during the
consultation. 108 (42.9%) patient interventions were found to be based on ... Cited by 13 - Related articles - BL Direct - All 9 versions
JS Schuman - eds, 2002 - informahealthcare.com Glaucoma, a leading cause of blindness worldwide, is a chronic neurodegen-
erative disorder. Patients with glaucoma may require long-term administra- tion
of intraocular pressure (IOP)-lowering medications. These medications ... Cited by 12 - Related articles - All 5 versions
JP Nordmann, A Lafuma, C Deschaseaux, G … - Journal of glaucoma, 2005 - journals.lww.com Skip Navigation Links Home > December 2005 - Volume 14 - Issue 6 > Clinical
Outcomes of Glaucoma Treatments Over a Patient Life... ... From *Hôpital des
Quinze-Vingts, Centre Hospitalier National d'Ophtalmologie, Paris, France; ... Cited by 13 - Related articles - BL Direct - All 3 versions
- ►nih.gov FA Knox, M Barry, B McGowan, CO'Brien - British journal of ophthalmology, 2006 - bjo.bmj.com Methods: A retrospective analysis was performed of drug costs, prescribing data,
and operation rates for glaucoma in Ireland from January 1996 to December 2003.
Information regarding costs and volume were obtained for each type of ... Cited by 10 - Related articles - BL Direct - All 7 versions
T Shaarawy, J Flammer, IO Haefliger - Eye, 2004 - nature.com Reducing IOP is presently the evidence based, most accepted and most practised
therapeutical approach for glaucoma patients. Currently topical ocular
hypotensive medications, with its different classes, as well as filtering ... Cited by 4 - Related articles - All 3 versions
C Costagliola, R dell'Omo, MR Romano, M … - Expert Opinion on Pharmacotherapy, 2009 - informahealthcare.com Elevated intraocular pressure (IOP) has been recognized as the major risk factor
for the development of glaucoma and a wide range of options are now available to
reduce it: medical treatment, laser, filtering, or cyclodestructive surgery ...
НИ Курышева - Глаукома, 2006 - glaucomajournal.ru В етаксолол — первый кардио- селективный
β1-адренерги- ческий антагонист для мест-
ного лечения глаукомы — был пред- ложен в ... Related articles - View as HTML - All 2 versions
MJ Lohse, B Müller-Oerlinghausen - Springer Die Psychopharmaka lassen sich in fünf große Gruppen unterteilen (Abbildung
42.1): Tranquillantien (ganz überwiegend Benzodiaze- pine), Antidepressiva und
Neuroleptika, wobei hier jeweils Präparate mit unterschiedlicher ... Related articles - All 2 versions
